These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 133756

  • 1. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
    Schein PS, Panasci L, Woolley PV, Anderson T.
    Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
    [Abstract] [Full Text] [Related]

  • 2. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T, McMenamin MG, Schein PS.
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC, Green D, Schein PS.
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [Abstract] [Full Text] [Related]

  • 5. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS, McMenamin MG, Anderson T.
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract] [Full Text] [Related]

  • 6. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA, Fox P, Schein PS.
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE, Green D, Schein PS.
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [Abstract] [Full Text] [Related]

  • 8. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Heal JM, Fox PA, Doukas D, Schein PS.
    Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.
    Panasci LC, Fox PA, Schein PS.
    Cancer Res; 1977 Sep; 37(9):3321-8. PubMed ID: 141978
    [No Abstract] [Full Text] [Related]

  • 10. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
    Ahlgren JD, Green DC, Tew KD, Schein PS.
    Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
    [Abstract] [Full Text] [Related]

  • 11. Review of mechanism of action studies of the nitrosoureas.
    Bono VH.
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract] [Full Text] [Related]

  • 12. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F, Giblin J, Berger M, Murphy MJ, Rosenblum ML.
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [Abstract] [Full Text] [Related]

  • 13. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M, Sakurai Y.
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [Abstract] [Full Text] [Related]

  • 14. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.
    Panasci LC, Green D, Nagourney R, Fox P, Schein PS.
    Cancer Res; 1977 Aug; 37(8 Pt 1):2615-8. PubMed ID: 141323
    [No Abstract] [Full Text] [Related]

  • 15. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ, Jasmin C, Hayat M, MacDonald JS, Mathé G.
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract] [Full Text] [Related]

  • 16. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV, Peretolchina NM, Minenkova EA, Verovskiĭ VN, Sof'ina ZP.
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [Abstract] [Full Text] [Related]

  • 17. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP, Schein PS.
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract] [Full Text] [Related]

  • 18. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS, Hoth D, Schein PS.
    Recent Results Cancer Res; 1980 Jan; 70():83-9. PubMed ID: 6444466
    [Abstract] [Full Text] [Related]

  • 19. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
    Bedford P, Eisenbrand G.
    Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
    [Abstract] [Full Text] [Related]

  • 20. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
    Kato T, Ota K.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.